Back to company

JJ PHARMA CONSULT ApS: Financial statements 2014

CVR: 33257635

JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -22,985 and a net result of DKK 920,163 compared with DKK 94,586 the year before. Equity amounted to DKK 933,614. The solvency ratio was 98.5%.

Gross Profit
-22,985 kr.
Profit/Loss
920,163 kr.
Equity
933,614 kr.
Total Assets
948,071 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--23 t.920 t.934 t.-
2013--9 t.95 t.183 t.-
2012--6 t.22 t.89 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on JJ PHARMA CONSULT ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

JJ PHARMA CONSULT ApS: The 2013 annual report is outApr 24, 2014

JJ PHARMA CONSULT ApS has published its annual report for 2013. Gross profit came to DKK -8,909, and the net result was DKK 94,586.

About JJ PHARMA CONSULT ApS

JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.